Skip to main content
HighTide Therapeutics, Inc. logo

HighTide Therapeutics, Inc. — Investor Relations & Filings

Ticker · 2511 HKEX Manufacturing
Filings indexed 99 across all filing types
Latest filing 2023-12-20 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2511

About HighTide Therapeutics, Inc.

http://www.hightidetx.com

HighTide Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative, multifunctional, multi-targeted therapies. The company is dedicated to addressing unmet needs within the spectrum of inter-related chronic metabolic diseases, specifically emphasizing Cardiovascular-Kidney-Metabolic (CKM) conditions. HighTide's therapeutic strategy targets diseases driven by underlying mechanisms such as insulin resistance and chronic inflammation. The product pipeline includes five candidates covering nine indications in metabolic and digestive diseases. The lead candidate, HTD1801, is currently being advanced in chronic metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis), Type 2 Diabetes Mellitus (T2DM), Obesity, Primary Sclerosing Cholangitis (PSC), and Chronic Kidney Disease (CKD), utilizing its dual mechanism of action.

Recent filings

Filing Released Lang Actions
TERMS OF REFERENCE FOR THE AUDIT COMMITTEE
Regulatory Filings
2023-12-20 English
Documents on Display
Regulatory Filings Classification · 1% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2023-12-13 English
GLOBAL OFFERING
Regulatory Filings
2023-12-13 English
GLOBAL OFFERING
Regulatory Filings
2023-12-13 English
PHIP (1st submission)
Regulatory Filings
2023-12-10 English
PHIP (1st submission)
Regulatory Filings Classification · 1% confidence The document is a landing page from the HKEX (Hong Kong Stock Exchange) website for a 'PHIP' (Post-Hearing Information Proof). A PHIP is a preliminary document filed by a company intending to list on the stock exchange, containing detailed information about the business, financials, and the offering structure. This is a classic IPO-related filing. Among the provided categories, 'Regulatory Filings' (RNS) serves as the appropriate fallback for IPO-related documentation that does not fit into specific categories like 'Annual Report' or 'Earnings Release'.
2023-12-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.